Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

06 sept. 2023 04h00 HE | Source: Proteros biostructures GmbH

Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with the full chemistry support of Enamine

Multi-target research partnership for drug discovery in oncology and painAssembly of novel high-diversity small molecule library Library collection distinguished by novel unique design concepts based...
09 janv. 2023 04h00 HE | Source: Proteros biostructures GmbH

Proteros receives minority investment from private equity firm Inflexion

MARTINSRIED, Germany and MUNICH, Germany, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Proteros biostructures GmbH, a leading German-based, founder-led contract research organization focused on early-stage...
25 oct. 2022 08h00 HE | Source: Proteros biostructures GmbH

Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases

Proteros selected by Adrestia for its cutting-edge structure-based drug discovery engineProteros to support Adrestia in the discovery of first-in-class drugs for intractable genetic diseasesSignals...